"The Skagit Regional Health Cancer Care Center provides expert cancer care to residents in Northwest Washington. Our team of highly-trained cancer specialists provide comprehensive cancer care services to families across Skagit, Island and north Snohomish counties."

During the past decade, Skagit Valley Hospital Regional Cancer Care Center conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 28 clinical trials were completed, i.e. on average, 215.4% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 15 clinical trials were completed. i.e. 1500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skagit Valley Hospital Regional Cancer Care Center" #1 sponsor was "SWOG Cancer Research Network" with 41 trials, followed by "National Cancer Institute (NCI)" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "GOG Foundation" with 3 trials sponsored and "Gynecologic Oncology Group" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skagit Valley Hospital Regional Cancer Care Center" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "Eastern Cooperative Oncology Group" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Skagit Valley Hospital Regional Cancer Care Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials), "Lymphoma" (6 trials) and "Recurrent Fallopian Tube Carcinoma" (4 trials). Many other conditions were trialed in "Skagit Valley Hospital Regional Cancer Care Center" in a lesser frequency.

Most popular intervention types in "Skagit Valley Hospital Regional Cancer Care Center" are "Drug" (52 trials), "Other" (33 trials), "Biological" (17 trials), "Procedure" (10 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (19 trials), "Quality-of-Life Assessment" (10 trials), "Paclitaxel" (9 trials), "paclitaxel" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Skagit Valley Hospital Regional Cancer Care Center" are 44 trials for "All" genders and 23 trials for "Female" genders.

Currently, there are NaN active trials in "Skagit Valley Hospital Regional Cancer Care Center". undefined are not yet recruiting, 1 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in Skagit Valley Hospital Regional Cancer Care Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Skagit Valley Hospital Regional Cancer Care Center, 2 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".